University of Colorado Anschutz

Does inducing labor increase the likelihood of a C-section? A new retrospective review from researchers at the University of Colorado Anschutz College of Nursing found that labor induction was not associated with a higher risk of cesarean birth among more than 7,300 midwife attended births across three Colorado hospitals. The study also found that pregnancy beyond 41 weeks—not induction itself—was associated with higher C-section rates.

Read More: https://bit.ly/4vUWSb4.

Osteoarthritis is one of the leading causes of chronic pain and disability — but new regenerative medicine research at may change how it’s treated.

Dr. Karin Payne, associate professor of orthopedics, explains how groundbreaking injectable biomaterials and regenerative therapies could help regrow damaged cartilage, reduce pain and restore healthy joint function without surgery.

Her team’s research focuses on treatments that recruit the body’s own cells to regenerate healthy cartilage to slow or reverse osteoarthritis — offering new hope for patients living with joint disease.

Can cartilage be regenerated? New osteoarthritis research at CU Anschutz Osteoarthritis is one of the leading causes of chronic pain and dis...

Bemotrizinol, a sunscreen ingredient that offers broad-spectrum, long-lasting protection with a less sticky feel, has been approved by the FDA for use in the United States.

dermatologist Theresa Pacheco, MD, shares why this approval is a big deal and how bemotrizinol works differently to block the sun's rays. 👇 🌞

Newly Approved Sunscreen Ingredient Promises ‘Broad, Reliable’ Protection A sunscreen ingredient that offers safe, long-lasting protection has been OK'd for use in the U.S. A CU Anschutz dermatologist applauds the decision.

After spending nearly 10 years unable to walk without assistance, Colorado resident Lynn Montgomery-Haga is walking freely again. Lynn was the first patient enrolled in a CAR T-cell clinical trial that researchers hope will transform treatment for stiff person syndrome.

Led by Amanda Piquet, MD, director of the Autoimmune Neurology Program, the clinical trial could lead to the first FDA-approved treatment for stiff person syndrome and the first CAR T-cell therapy ever approved for any autoimmune disease.

The trial results have been promising, with eight of 12 participants who relied on wheelchairs or walking aids regaining independent walking during testing.

💫 Learn More: https://bit.ly/4fIKqqc.

researchers have published a proof-of-concept study demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS.

“Women with PMOS frequently face a frustrating choice between treatments that target reproductive symptoms and those that address metabolic health,” says Melanie Cree, MD, PhD, first author of the report. "Our early findings suggest injectable semaglutide may have the potential to improve both."

Read More: https://bit.ly/4uZEfm9.

Join us for a special Independence Eve celebration with the Colorado Symphony on July 3 at the Buell Theatre in downtown Denver. 🇺🇸

Presented by , this free community concert honors veterans, active-duty military service members and their families while celebrating America’s 250th anniversary and Colorado’s 150th birthday.

Supporting those who serve is central to our mission. The CU Anschutz Combat Medicine Research Center helps solve the toughest problems in military medicine and translate those advances into better care for all, while the CU Anschutz Marcus Institute for Brain Health provides specialized care and research for veterans, service members and first responders living with traumatic brain injury and post-traumatic stress.

Enjoy an evening of patriotic favorites and iconic American music: https://bit.ly/3PQ67dp

Cancer survivorship rates for nearly every type of cancer have increased over the past 20 years. On National Cancer Survivors Day, we recognize survivors and the research that continues to advance care.

As Colorado's only National Cancer Institute-designated comprehensive cancer center, the University of Colorado Anschutz Cancer Center is developing new and better approaches to prevention, diagnosis and treatment through groundbreaking research and clinical trials.

🔗 Learn more: https://bit.ly/4xlI8Uj

New research from found that stress can change tiny molecules in s***m that may help shape how a baby develops in the earliest stages of life. These changes don't affect DNA itself, but they may influence growth and development later on.

The findings add to growing evidence that a parent's health and experiences before pregnancy may play a role in a child's development.

🔗 Read more: https://bit.ly/4o8jUZk

Campus in June. 🌼🌿